Amplify Weight Loss Drug & Treatment ETF (THNR)
26.49
+0.11
(+0.42%)
USD |
NYSEARCA |
Feb 20, 13:39
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.59% | -0.08% | 4.488M | 4144.53 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 1.83% | 70.00% | -600836.0 |
Basic Info
| Investment Strategy | |
| The Fund seeks investment results that generally correspond to the performance of the VettaFi Weight Loss Drug & Treatment Index. It invests at least 80% of its net assets in securities that comprise the Index which is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Amplify ETFs |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of February 20, 2026.
Asset Allocation
As of January 31, 2026.
| Type | % Net |
|---|---|
| Cash | 0.68% |
| Stock | 98.78% |
| Bond | 0.35% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.19% |
Basic Info
| Investment Strategy | |
| The Fund seeks investment results that generally correspond to the performance of the VettaFi Weight Loss Drug & Treatment Index. It invests at least 80% of its net assets in securities that comprise the Index which is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Amplify ETFs |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |